PHT-1
PT
Menu
Search

Sections

  • Home
  • News
  • Analysis
    • Features
    • Comment
    • Data Insights
    • Projects
  • Sectors
    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Disease
      • Oncology
      • Respiratory
  • Themes
    • Artificial Intelligence
    • Corporate Governance
    • Cloud
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19
  • Insights
    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content
  • Pricing and Market Access
  • Events
  • Reports
  • Awards & Rankings
  • Magazine

GlobalData

  • About us
  • Advertise With Us
  • Contact Us
  • Our Marketing Solutions
  • GlobalData Reports
  • Visit GlobalData

From Our Partners

  • Precision medicine and digital health innovation for disease diagnosis, care and treatment
  • Enabling process intensification in biopharma manufacturing
  • Specialty drug launch strategy and operations
  • The next chapter of clinical trial services
  • Future Pharma Services
  • Putting quality first in the pharma supply chain
  • Enabling better biopharmaceutical manufacturing
  • Pharmaceutical Grade Silicone Manufacturer
  • Maximising molecule potential
  • News
  • Analysis

    Sections

    • Features
    • Comment
    • Data Insights
    • Projects

    Latest

    • Pharma Fix: The quest for the next tuberculosis vaccine
    • Pfizer acquires ADC pioneer Seagen for $43bn
    • Biotech’s post-IPO boom: rebounding from a 2022 Low?
  • Sectors

    Sections

    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area

    Latest

    • Alnylam’s Manufacturing Facility, Norton, Massachusetts
    • China’s NMPA grants conditional approval for AstraZeneca’s Calquence
    • Takeda set to build $764m manufacturing facility in Japan
  • Themes

    Sections

    • Artificial Intelligence
    • Cloud
    • Corporate Governance
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19

    Latest

    • Takeda set to build $764m manufacturing facility in Japan
    • Klinge Corporation
    • TRiBECA® Knowledge
  • Insights

    Sections

    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media

    Latest

    • Merck reports rise in group net sales in fiscal 2022
    • AbbVie reports rise in full-year 2022 net revenues
    • Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content

    Latest

    • Aseptic lyophilisation: Opportunities to improve quality and process monitoring with mass spectrometry
    • Optimising biopharma production through process intensification
    • Quality first: How pharma can meet injectables demand while staying compliant
  • Events
  • Reports
PT
October 19, 2016

4th International Conference on Chronic Obstructive Pulmonary Disease

IndiaProduction

Share this article

IndiaProduction

Recommended Reports

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical...

Pituitary Tumors Global Clinical Trials Review, Q4, 2010

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical...

3rd World Congress on Controversies in Ophthalmology 2012 - ...

PharmaPoint: Chronic Obstructive Pulmonary Disease – Global ...

View All

Companies Intelligence

View All
PharmaceuticalTechnology

The leading site for news and procurement in the pharmaceutical industry

  • About us
  • Advertise with us
  • Contact us
  • Editorial approach
  • Newsletters
  • Our marketing solutions
  • Privacy policy
  • Terms and conditions

Powered by Pharma Tech Logo

© Verdict Media Limited 2023

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.